Replies to post #5030 on Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

".... hoping for big changes under Dr.Gottlieb!
Who knows, maybe some conditional approval may be possible, ...."

Good point- what are they waiting for? Why not approve treatment today and do a Phase 4 instead? VOC has been thoroughly tested by more than 2000 people and shown to be very safe, it's shown to be effective as well so the downside is either very small or non-existent.

Seems stupid when the upside of helping suffering people (saving lives) is considered. Hate the bureaucratic overkill rules and regs of gov't.

No wonder the average cost of bringing a new drug to market in the USA is something like 2.6 billion and takes years and years.

There has to be a better way.

[grandma_of_jbraika]

zzaattt only:"AUPH is run by a management team with deep experience in lupus nephritis (LN) and corporate development, having executed the ALMS study for CellCept and selling Aspreva and ZymoGenetics to large pharma companies ... " - https://www.docdroid.net/CIKaxJ9/aurinia-pharmaceuticals-inc-leerink1.pdf

Hotrodder/Foxxy says nobody my posts about AUPH. LOL!

[grandma_of_jbraika]

"ILJIN's Hyuek Joon Lee is on AUPH's board of directors. ILJIN knows about any of the Voclosporin stories definitely better than BR, humour412, socialidiocies and Flyingtrader. ILJIN has been being the absolutely #1 AUPH owner/investor since 2011. Why did ILJIN still acquire 20+% or 5,185,185 shares of the 25,645,000 shares offered publicly on 03-13-2017? AUPH is good, isn't it? LJIN owns 17.35% of AUPH (14,205,457 shares) now after it added 5,185,185 shares at $6.75 in March. I don't think Katrina's confidence on AUPH would be shaken by BR and humour412."

https://relationshipscience.com/hyuek-joon-lee-p157816980

Dr. Hyuek Joon Lee is the Director of New Business Development for ILJIN Group and is responsible for mergers and acquisitions, and managing overseas investments, joint ventures and subsidiaries. As of October 2014 he joined the board of directors of Life Science Enterprises in Massachusetts, ..." Link: http://insiders.morningstar.com/trading/executive-profile.action?t=0P0000BLCT&PersonId=PS0000A8VP&flag=Director&insider=Hyuek_Lee&culture=en-CA&productcode=CAN&ops=clear&cur=



This is Posted by ariadinvestor:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH

[grandma_of_jbraika]

I like your intuitions on
picking a good investment, AND your dogged stubborness in sticking
with your convictions. It's not a guarantee that it will work
out, BUT is sure did with Ariad, and I believe it will also
have similar results here (minus the drama there).

I cannot think of another biotech where the probability
for a favorable outcome is as good as AUPH. The people
running the show are top notch, have deep experience in
both the specific science (LN related issues), and the
business acumen based on a very similar (almost
the same) medical and business situation.

While it might take two years for approval, I think we'll
see upward movement before that, after all, Aurinia does
have other indications for Voc. and potential for deal-making.


Good luck to you and fellow longs,
zzaatt/amp

PS: This two year (blinded) wait seems pretty grotesque, given the
strong results in P2 and the fact that it will cost the lives
of thousands of very desperate patients. I always had a
profound contempt for the corrupt, hide-bound bureaucracy
known as the FDA and I'm hoping for big changes under Dr.Gottlieb!
Who knows, maybe some conditional approval may be possible,
it certainly should be, if the goal is to help sick people.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=133437830

".... hoping for big changes under Dr.Gottlieb!
Who knows, maybe some conditional approval may be possible, ...."

Good point- what are they waiting for? Why not approve treatment today and do a Phase 4 instead? VOC has been thoroughly tested by more than 2000 people and shown to be very safe, it's shown to be effective as well so the downside is either very small or non-existent.

Seems stupid when the upside of helping suffering people (saving lives) is considered. Hate the bureaucratic overkill rules and regs of gov't.

No wonder the average cost of bringing a new drug to market in the USA is something like 2.6 billion and takes years and years.

There has to be a better way.

http://investorshub.advfn.com/boards/replies.aspx?msg=133437830